{"abstract": "Carl C. Icahn may have been pleased to learn that one of his adversaries, James C. Mullen, the chief executive of Biogen Idec, is retiring as president and chief executive of the firm as of June 8.", "web_url": "https://dealbook.nytimes.com/2010/01/05/biogen-chief-and-icahn-adversary-to-retire/", "snippet": "Carl C. Icahn may have been pleased to learn that one of his adversaries, James C. Mullen, the chief executive of Biogen Idec, is retiring as president and chief executive of the firm as of June 8.", "lead_paragraph": "Carl C. Icahn may be pleased to learn that one of his adversaries, James C. Mullen, the chief executive of Biogen Idec, is retiring as president and chief executive of the company as of June 8.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Biogen Chief and Icahn Adversary to Retire", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Icahn, Carl C", "rank": 1, "major": "N"}, {"name": "persons", "value": "Mullen, James C", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Biogen Idec Incorporated", "rank": 3, "major": "N"}, {"name": "glocations", "value": "Massachusetts", "rank": 4, "major": "N"}], "pub_date": "2010-01-05T09:36:45+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/4d3cf737-5241-5ef5-b4b5-6e27af0e09bf", "word_count": 293, "uri": "nyt://article/4d3cf737-5241-5ef5-b4b5-6e27af0e09bf"}